Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CREB1K292 and HINFPK330 as Putative Common Therapeutic Targets in Alzheimer’s and Parkinson’s Disease

16 Dec 2021

Abstract excerpt

Integration of omics data and deciphering the mechanism of a biological regulatory network could be a promising approach to reveal the molecular mechanism involved in the progression of complex diseases, including Alzheimer's and Parkinson's. Despite having an overlapping mechanism in the etiology of Alzheimer's disease (AD) and Parkinson's disease (PD), the exact mechanism and signaling molecules behind them are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Bioinformatics and Genomic Networks
Share to Histone Deacetylase Inhibitors Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34984308
DOI: 10.1021/acsomega.1c05827

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CREB1K292 and HINFPK330 as Putative Common Therapeutic Targets in Alzheimer’s and Parkinson’s DiseasePMID 34984308Read ↗

Identification of Common Molecular Signatures Shared between Alzheimer’s and Parkinson’s Diseases and Therapeutic Agents Exploration: An Integrated Genomics ApproachSemantic proximity Read ↗

Bioinformatic identification and experiment validation reveal 6 hub genes, promising diagnostic and therapeutic targets for Alzheimer’s diseaseSemantic proximity Read ↗

Genetic networks in Parkinson’s and Alzheimer’s diseaseSemantic proximity Read ↗

Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in Alzheimer’s diseaseSemantic proximity Read ↗

Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markersSemantic proximity Read ↗

Identification of candidate biomarkers and signaling pathways associated with Alzheimer’s disease using bioinformatics analysis of next generation sequencing dataSemantic proximity Read ↗

Identification of key genes and pathways for Alzheimer’s disease via combined analysis of genome-wide expression profiling in the hippocampusSemantic proximity Read ↗

Identification of biomarkers and pathways to identify novel therapeutic targets in Alzheimer’s disease: Insights from a systems biomedicine perspectiveSemantic proximity Read ↗

Identification of novel hub genes for Alzheimer’s disease associated with the hippocampus using WGCNA and differential gene analysisSemantic proximity Read ↗

Related Network and Differential Expression Analyses Identify Nuclear Genes and Pathways in the Hippocampus of Alzheimer DiseaseSemantic proximity Read ↗

Investigating Gene Expression Datasets of Hippocampus Tissue to Discover Alzheimer's Disease-Associated Molecular MarkersSemantic proximity Read ↗

Identification of KIAA0513 and Other Hub Genes Associated With Alzheimer Disease Using Weighted Gene Coexpression Network AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.